IDiyas

For the Inventor, By the Inventor

Chennai, India

Parthasarathi Rajagopalan

USPTO Granted Patents = 13 

Average Co-Inventor Count = 2.1

ph-index = 5

Forward Citations = 69(Granted Patents)


Location History:

  • Wilmington, DE (US) (1982 - 2004)
  • Chennai, IN (2010 - 2013)

Company Filing History:

goldMedal5 out of 16,338 
 
E.i. Dupont De Nemours and Company
 patents
silverMedal2 out of 106 
 
Dupont Pharmaceuticals Company
 patents
bronzeMedal2 out of 206 
 
The Dupont Merck Pharmaceutical Company
 patents
4. 2 out of 27 
 
Jenrin Discovery, Inc.
 patents
5. 1 out of 15 
 
Dupont Pharmaceuticals, Inc.
 patents
6. 1 out of 10 
 
Bristol-myers Squibb Pharma Corporation
 patents

Years Active: 1982-2013

Loading Chart...
13 patents (USPTO):Explore Patents
1. 8541475 - MAO-B inhibitors useful for treating obesity (2013-09-24),
2. 7649115 - MAO-B inhibitors useful for treating obesity (2010-01-19),
3. 6818648 - Aryloxy- and arylthiosubstituted pyrimidines and triazines and derivatives thereof (2004-11-16),
4. 6326368 - Aryloxy- and arylthiosubstituted pyrimidines and triazines and derivatives thereof (2001-12-04),
5. 6258809 - 6-aryloxy and arylthiopurines (2001-07-10),
6. 6124300 - Aryloxy- and arylthio- fused pyridines and pyrimidines and derivatives (2000-09-26),
7. 5321023 - Pyridoindolobenzodiazepines and derivatives as antipsychotics (1994-06-14),
8. 5043350 - Benzo-fused cycloalkane and oxa- and thia-, cycloalkane (1991-08-27),
9. 5010085 - Benzo-fused cycloalkane and oxa- and thia-cycloalkane trans-1,2-diamine (1991-04-23),
10. 4929627 - Benzo-fused cycloalkane and oxa- and thia-, cycloalkane (1990-05-29),
11. 4876269 - Benoz-fused cycloalkane trans-1,2-diamine derivatives (1989-10-24),
12. 4438120 - Pyridoindolobenzodiazepine tranquilizers (1984-03-20),
13. 4351836 - 1,2,3,4,4a,5,10,10a-Octahydro-5,10-ortho-benzenobenz[g]isoquinolines and (1982-09-28),

Title: Parthasarathi Rajagopalan - Innovator in Monoamine Oxidase-B Inhibitors

Introduction

Parthasarathi Rajagopalan is a distinguished inventor based in Chennai, India. He holds a remarkable portfolio of 13 patents, showcasing his contributions to the field of pharmaceuticals, particularly in addressing metabolic disorders.

Latest Patents

Among his notable inventions, Parthasarathi's latest patents include innovative compounds that serve as monoamine oxidase-B (MAO-B) inhibitors. These compounds are specifically designed to tackle obesity, diabetes, and various cardiometabolic disorders, such as hypertension, dyslipidemias, high blood pressure, and insulin resistance. His work in developing these novel compounds underscores his commitment to advancing healthcare solutions.

Career Highlights

Throughout his career, Parthasarathi has been associated with prominent organizations including E.I. du Pont de Nemours and Company and DuPont Pharmaceuticals Company. His experiences at these companies have not only forged his expertise in pharmaceuticals but also allowed him to contribute significantly to the development of innovative therapeutic solutions.

Collaborations

Parthasarathi has collaborated with notable figures in the scientific community, including Robert J. Chorvat and Penio Pennev. These partnerships have been instrumental in progressing his research and enhancing the impact of his inventions within the industry.

Conclusion

In summary, Parthasarathi Rajagopalan is a significant figure in the field of pharmaceuticals, particularly through his innovative work on MAO-B inhibitors. His contributions to science and medicine continue to address critical health issues, solidifying his reputation as an influential inventor in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…